oral glp-1 tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are Tirzepatide ODT | Oral GLP-1

2025, pp

Common Mistakes to Avoid Learning from others mistakes can help you optimize your results and avoid common pitfalls

Ozempics fame risks leaving the people it was made for behind Ozempic and similar drugs weight-loss benefits have made it hard for people with diabetes and related health issues to access what some see as a life-saving medication

Lets explore what retatrutide is, where you can legitimately access it, and what alternatives might be available while you wait for potential FDA approval

After reconstitution, store at 2-8C and use within 14 days

GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment